These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21036226)

  • 1. Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis.
    Mokrosiński J; Holst B
    Methods Enzymol; 2010; 484():53-73. PubMed ID: 21036226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique interaction pattern for a functionally biased ghrelin receptor agonist.
    Sivertsen B; Lang M; Frimurer TM; Holliday ND; Bach A; Els S; Engelstoft MS; Petersen PS; Madsen AN; Schwartz TW; Beck-Sickinger AG; Holst B
    J Biol Chem; 2011 Jun; 286(23):20845-60. PubMed ID: 21402696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for agonism in the BB3 receptor: an epitope located on the interface of transmembrane-III, -VI, and -VII.
    Gbahou F; Holst B; Schwartz TW
    J Pharmacol Exp Ther; 2010 Apr; 333(1):51-9. PubMed ID: 20065020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of tryptophan W276 and of two surrounding amino acid residues in the high constitutive activity of the ghrelin receptor GHS-R1a.
    Gozé C; Bergé G; M'Kadmi C; Floquet N; Gagne D; Galleyrand JC; Fehrentz JA; Martinez J
    Eur J Pharmacol; 2010 Sep; 643(2-3):153-61. PubMed ID: 20599926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
    Els S; Beck-Sickinger AG; Chollet C
    Methods Enzymol; 2010; 485():103-21. PubMed ID: 21050913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities.
    Liu G; Fortin JP; Beinborn M; Kopin AS
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1036-43. PubMed ID: 17596538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor.
    Els S; Schild E; Petersen PS; Kilian TM; Mokrosinski J; Frimurer TM; Chollet C; Schwartz TW; Holst B; Beck-Sickinger AG
    J Med Chem; 2012 Sep; 55(17):7437-49. PubMed ID: 22920150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisubstituted 1,2,4-triazoles as ligands for the ghrelin receptor: on the significance of the orientation and substitution at position 3.
    Moulin A; Demange L; Ryan J; M'Kadmi C; Galleyrand JC; Martinez J; Fehrentz JA
    Bioorg Med Chem Lett; 2008 Jan; 18(1):164-8. PubMed ID: 18023181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of high Basal signaling from the ghrelin receptor.
    Petersen PS; Woldbye DP; Madsen AN; Egerod KL; Jin C; Lang M; Rasmussen M; Beck-Sickinger AG; Holst B
    Endocrinology; 2009 Nov; 150(11):4920-30. PubMed ID: 19819980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminus of a hexapeptidic ghrelin receptor inverse agonist can switch peptide behavior from inverse agonism to agonism.
    Els-Heindl S; Bellmann-Sickert K; Beck-Sickinger AG
    Biopolymers; 2016 Jan; 106(1):101-8. PubMed ID: 26566778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.
    Holst B; Cygankiewicz A; Jensen TH; Ankersen M; Schwartz TW
    Mol Endocrinol; 2003 Nov; 17(11):2201-10. PubMed ID: 12907757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.
    Holst B; Nygaard R; Valentin-Hansen L; Bach A; Engelstoft MS; Petersen PS; Frimurer TM; Schwartz TW
    J Biol Chem; 2010 Feb; 285(6):3973-3985. PubMed ID: 19920139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism.
    Holst B; Mokrosinski J; Lang M; Brandt E; Nygaard R; Frimurer TM; Beck-Sickinger AG; Schwartz TW
    J Biol Chem; 2007 May; 282(21):15799-811. PubMed ID: 17371869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists.
    Ramirez VT; van Oeffelen WEPA; Torres-Fuentes C; Chruścicka B; Druelle C; Golubeva AV; van de Wouw M; Dinan TG; Cryan JF; Schellekens H
    FASEB J; 2019 Jan; 33(1):518-531. PubMed ID: 30020830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues.
    Chollet C; Meyer K; Beck-Sickinger AG
    J Pept Sci; 2009 Nov; 15(11):711-30. PubMed ID: 19787814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
    Peng JY; Vaidehi N; Hall SE; Goddard WA
    ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.